ATAI Life Sciences NV Financial Flexibility Index
ATAI Life Sciences NV financial flexibility index. ATAI Life Sciences NV (9VC) has a Financial Flexibility Index of -0.22x as of September 2025. Free cash flow of €-17.90 Million (operating CF €-23.26 Million minus capex €5.36 Million) represents 0% of total liabilities (€79.91 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of ATAI Life Sciences NV (2019–2024)
Financial flexibility index of ATAI Life Sciences NV from 2019 to 2024. Historical Financial Flexibility Index trend for ATAI Life Sciences NV across 6 annual periods. Check how high is ATAI Life Sciences NV's earnings quality to evaluate the quality of earnings relative to operating cash generation.
ATAI Life Sciences NV Financial Flexibility Index by Year (2019–2024)
ATAI Life Sciences NV financial flexibility index by year from 2019 to 2024. Year-by-year free cash flow to debt coverage for ATAI Life Sciences NV. For the full cash flow conversion analysis, see ATAI Life Sciences NV (9VC) cash conversion ratio.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -1.92x | €-82.34 Million | €-82.44 Million | €42.83 Million | ▼ -13.1% |
| 2023 | -1.70x | €-83.53 Million | €-84.12 Million | €49.16 Million | ▲ +34.8% |
| 2022 | -2.61x | €-103.44 Million | €-104.47 Million | €39.67 Million | ▼ -18.4% |
| 2021 | -2.20x | €-62.12 Million | €-63.25 Million | €28.21 Million | ▼ -72.1% |
| 2020 | -1.28x | €-20.71 Million | €-20.77 Million | €16.18 Million | ▲ +59.5% |
| 2019 | -3.16x | €-7.83 Million | €-7.85 Million | €2.48 Million | — |